相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of the most specific markers to differentiate primary pulmonary carcinoma from metastatic gastrointestinal carcinoma to the lung
Bachar Alabdullah et al.
DIAGNOSTIC PATHOLOGY (2022)
Clinicopathological characteristics and survival in lung signet ring cell carcinoma: A population-based study
Yunting Cai et al.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2021)
A case report of primary signet ring cell carcinoma of the lung: imaging study and literature review
Mingguang Yang et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2021)
Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life Cohort
Elizabeth Dudnik et al.
CLINICAL LUNG CANCER (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Survival in signet ring cell carcinoma varies based on primary tumor location: a Surveillance, Epidemiology, and End Results database analysis
San-Gang Wu et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2018)
FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring BRAF V600E Mutations
Lauretta Odogwu et al.
ONCOLOGIST (2018)
Gastrointestinal metastasis of primary lung cancer: An analysis of 366 cases
Yue Hu et al.
ONCOLOGY LETTERS (2018)
The mitogen-activated protein kinase pathway in melanoma part I - Activation and primary resistance mechanisms to BRAF inhibition
Teresa Amaral et al.
EUROPEAN JOURNAL OF CANCER (2017)
Role Played by Signalling Pathways in Overcoming BRAF Inhibitor Resistance in Melanoma
Xian Yang Chan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
David Planchard et al.
LANCET ONCOLOGY (2017)
Analysis of gastrointestinal metastasis of primary lung cancer: Clinical characteristics and prognosis
Naohiro Taira et al.
ONCOLOGY LETTERS (2017)
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)
Fabrice Barlesi et al.
LANCET (2016)
Epidemiology of Lung Cancer
Yousheng Mao et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad et al.
NATURE (2012)
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
Julian R. Molina et al.
MAYO CLINIC PROCEEDINGS (2012)
EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF-Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
Ryan B. Corcoran et al.
CANCER DISCOVERY (2012)
Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Harboring BRAF Mutations
Antonio Marchetti et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
Robert Pirker et al.
LANCET (2009)
Gastrointestinal metastases from primary lung cancer
Akihiro Yoshimoto et al.
EUROPEAN JOURNAL OF CANCER (2006)
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003
DG Pfister et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
分享论文
